About Akhila Kosaraju
CEO at Phare Bio
Akhila Kosaraju is the President and CEO of Phare Bio, a biotech social venture harnessing generative AI for open-access antibiotic discovery to combat superbugs. Her work bridges AI/ML, health/biotech, entrepreneurship, design thinking, and policy, emphasizing open science, interdisciplinary innovation, and user-centered design to accelerate adoption of climate and health solutions. From early entrepreneurial ventures and climate UX design at WHAT IF Design to leading AI-driven biotech breakthroughs, she advocates for collaborative, accessible technologies that address global challenges.
Professional Background and Entrepreneurship
Akhila Kosaraju's entrepreneurial journey began with a childhood lemonade stand and evolved through her time as a University of Michigan Masters student, where she explored strengths-based career development and supported climate-positive businesses.[4][7] She co-founded WHAT IF Design, focusing on UX to drive sustainability adoption, before transitioning to biotech leadership as President and CEO of Phare Bio.[10]
AI and Machine Learning in Biotech
Kosaraju champions generative AI for antibiotic discovery at Phare Bio, an open-access platform targeting superbugs amid a crisis with few new antibiotics.[6][13][17][18][19][22] Phare Bio's innovations earned recognition in Fast Company's 2025 World Changing Ideas, AI Impact Awards, and Google.org Accelerator.[14][17][19] She highlights AI's role in uncovering 'needles in haystacks' for drug discovery.[22]
Open Science and Policy Advocacy
A vocal proponent of open science in biotech, Kosaraju argues for data sharing, public funding, and incentives to overcome market failures in antibiotic development.[6][21] Her op-ed in The Hill outlines strategies like AI-enabled platforms to usher in a 'golden age' of discovery.[6][21]
Design Thinking and Adoption
Early work emphasized UX design to bridge the 'adoption gap' for climate solutions, noting that pilots succeed but scaling requires user-centric design.[1][3][5][9][10] She critiques common pitfalls like over-relying on homepages for conversions and highlights location-specific challenges for climate tech.[1][3][5]
Interdisciplinary Innovation and Health Impact
Kosaraju advocates interdisciplinary approaches combining AI, biotech, policy, and design for faster health breakthroughs.[15][16] Recognized at events like the World Changing Ideas Summit and Milken Institute, her vision positions AI as transformative for 2026 healthcare.[11][15][20]
Recognition and Influence
Phare Bio's work with MIT garnered major accolades, while Kosaraju's ideas on climate UX and open science have been shared and praised widely.[2][8][13][17]
AI-Driven Antibiotic Discovery
Leveraging generative AI for open-access platforms to combat superbugs and revive antibiotic innovation.
Open Science in Biotech
Advocates data sharing, public incentives, and collaborative models to address market failures.
User-Centered Design for Adoption
UX design critical for scaling climate and tech solutions beyond pilots.
Entrepreneurship and Innovation
From lemonade stands to biotech CEO, emphasizing strengths and interdisciplinary ventures.
Every entry that fed the multi-agent compile above. Inline citation markers in the wiki text (like [1], [2]) are not yet individually linked to specific sources — this is the full set of sources the compile considered.
- What if I told you that your most important conversion point is NOT ...article · 2026-04-14
- Thanks Akhila Kosaraju for the image and quote below | Ed Mitchardarticle · 2026-04-14
- Akhila Kosaraju's Post - LinkedInarticle · 2026-04-14
- Discovering Ways to Exercise Your Strengths at a New Companyarticle · 2026-04-14
- Your homepage isn't your only landing page. Every page on your ...article · 2026-04-14
- We need more open science in biotech — here's how we achieve itarticle · 2026-04-14
- Student Spotlight: Akhila Kosaraju – Center for Entrepreneurshiparticle · 2026-04-14
- Akhila Kosaraju — LDV Capital Blog on Visual Technologies and AI ...article · 2026-04-14
- Akhila Kosaraju's Post - LinkedInarticle · 2026-04-14
- Fixing the Adoption Gap: How UX Drives Real-World Sustainabilityarticle · 2026-04-14
- 10 insights from the World Changing Ideas Summit - Johns Hopkins in Washington, D.C.news_article · 2026-04-14
- New Acting CDC Director Named - Contagion Livenews_article · 2026-04-14
- AI is coming for superbugs - Fast Companynews_article · 2026-04-14
- AI Impact Awards 2025: How 7 Health Care Winners Measure Impact - Newsweeknews_article · 2026-04-14
- Transforming Health Care Through Technological Shifts - Milken Institutenews_article · 2026-04-14
- How an interdisciplinary approach is enabling faster health breakthroughs - Johns Hopkins in Washington, D.C.news_article · 2026-04-14
- Phare Bio and MIT Named to Fast Company’s 2025 World Changing Ideas List - Business Wirenews_article · 2026-04-14
- Researchers turn to AI for help fighting superbugs - CBCnews_article · 2026-04-14
- Phare Bio Selected to Participate in the Google.org Accelerator: Generative AI to Advance Open-Access Antibiotic Discovery Platform - Business Wirenews_article · 2026-04-14
- What will define 2026, according to leaders in space, healthcare, and AI - Fast Companynews_article · 2026-04-14
- We need more open science in biotech — here’s how we achieve it - The Hillnews_article · 2026-04-14
- Utilizing AI for Drug Discovery: Uncovering Needles in Haystacks - Contagion Livenews_article · 2026-04-14